Safety and Efficacy of Vadadustat Once Daily and Three Times Weekly in Patients With Dialysis-Dependent CKD With Anemia
Kidney360
.
2024 Nov 1;5(11):1652-1661.
doi: 10.34067/KID.0000000567.
Epub 2024 Sep 4.
Authors
Laura Kooienga
1
,
Steven Burke
2
,
Amarnath Kathresal
3
,
Wenli Luo
2
,
Zhihui Yang
2
,
Zhiqun Zhang
2
,
Rafal Zwiech
4
,
German T Hernandez
5
Affiliations
1
Colorado Kidney Care, Aurora, Colorado.
2
Akebia Therapeutics, Inc., Cambridge, Massachusetts.
3
Durham Nephrology Associates, PA, Durham, North Carolina.
4
Norbert Barlicki Memorial Teaching Hospital, Lodz, Poland.
5
El Paso Kidney Specialists, El Paso, Texas.
PMID:
39231617
DOI:
10.34067/KID.0000000567
No abstract available
Associated data
ClinicalTrials.gov/NCT04313153
ClinicalTrials.gov/NCT04707768
Grants and funding
Akebia Therapeutics